Hair-Loss Pill Maker Veradermics Seeks $213.6 Million in US IPO
Veradermics Inc., a biopharmaceutical firm focused on hair restoration, is seeking to raise as much as $213.6 million in an initial public offering to help commercialize its hair re-growth pill.
By Avalon Pernell · Bloomberg
Veradermics Inc., a biopharmaceutical firm focused on hair restoration, is seeking to raise as much as $213.6 million in an initial public offering to help commercialize its hair re-growth pill.